Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Brimonidine Tartrate Eye Drops

Approval Number

国药准字H20249428

Company四川智强医药科技开发有限公司

Registration Date

November 22, 2024

Drug Information

Generic Name

酒石酸溴莫尼定滴眼液

Dosage Form

眼用制剂

Strength

0.15%（0.3ml: 0.45mg）

Drug Type

化学药品

Registration Date

November 22, 2024

Company Information

Applicant Company

Company Name四川智强医药科技开发有限公司

Company Address

成都金牛高新技术产业园区兴盛西路2号1栋12楼1201号

Manufacturing Company

Company Name四川禾亿制药有限公司

Company Address

四川省成都市蒲江县鹤山街道工业南路67号

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy

酒石酸溴莫尼定滴眼液 - NMPA 批准文号 | MedPath